Angion Biomedica Corp. Analysis
| Analyst Ratings |
|
Average Target Price
|
1.50
|
|
Average Rating
|
3.00
|
|
# Strong Buys
|
0
|
|
# Buys
|
0
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.36
|
-0.30
|
0.06
|
16.67%
|
|
2022-06-30
|
-0.46
|
-0.30
|
0.16
|
34.78%
|
|
2022-03-31
|
-0.43
|
-0.48
|
-0.05
|
-11.63%
|
|
2021-12-31
|
-0.62
|
0.58
|
1.20
|
193.55%
|
|
2021-09-30
|
-0.72
|
-0.53
|
0.19
|
26.39%
|
|
2021-06-30
|
-0.69
|
-0.58
|
0.11
|
15.94%
|
|
2021-03-31
|
-0.62
|
-1.56
|
-0.94
|
-151.61%
|
|
2020-12-31
|
-1.30
|
-1.90
|
-0.60
|
-46.15%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.08
|
|
2021-12-31
|
-2.09
|
|
2020-12-31
|
-3.05
|
|
2013-12-31
|
0.05
|
|
2012-12-31
|
0.01
|